Browsing Tag
equity financing
9 posts
Will Dreamland’s $18m Hudson equity facility power an event expansion or lead to dilution?
Dreamland Limited inks $18M deal with Hudson Global Ventures. Find out what this flexible equity facility means for its Nasdaq listing and growth outlook.
Kala Bio launches $10m registered direct financing amid balance sheet reset and dilution concerns
Find out how Kala Bio’s $10 million at-the-market stock offering under Nasdaq rules is reshaping its balance sheet, dilution risk, and survival strategy.
HTCO taps investor funding for AI-driven shipping upgrade—can it deliver execution next?
HTCO closes $3M financing to accelerate AI platform and digital transformation in global shipping. Find out how this move signals investor confidence and tech-forward strategy.
Hyperscale Data fortifies balance sheet with $125m raise, doubling down on bitcoin-backed AI expansion
Find out how Hyperscale Data’s $125 million raise is powering its bold bitcoin-backed AI infrastructure expansion.
POET Technologies’ US$150m oversubscribed offering signals strong demand for its AI-driven photonics platform
Find out how POET Technologies’ US$150 million oversubscribed share offering strengthens its position in AI-driven photonics—read the full story here!
Serve Robotics just raised $100m — can this bold move finally make robot delivery mainstream?
Serve Robotics raises $100M to expand its autonomous delivery fleet and AI infrastructure — find out how this funding could reshape last-mile logistics.
NexGen Energy raises C$400m and A$400m — What this dual equity deal means for uranium investors
NexGen Energy is raising C$400M and A$400M in dual equity offerings to accelerate its Rook I uranium project. See what this means for investors.
Silver Storm Mining boosts private financing to C$4.0m amid La Parrilla revival
Silver Storm Mining upsizes its private placement to C$4.0 million to fund La Parrilla mine rehabilitation and equipment upgrades. Read the full update.
Protagonist Therapeutics secures $22m to advance IBD treatment
Protagonist Therapeutics, a clinical-stage biopharmaceutical company specializing in the discovery and development of novel peptide-based drugs, has successfully…